Bath & Body Works, Inc. $BBWI Shares Acquired by GMT Capital Corp

GMT Capital Corp increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 8.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 4,067,000 shares of the company’s stock after purchasing an additional 329,300 shares during the period. Bath & Body Works accounts for approximately 5.1% of GMT Capital Corp’s holdings, making the stock its 7th largest position. GMT Capital Corp owned about 1.92% of Bath & Body Works worth $121,847,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of BBWI. T. Rowe Price Investment Management Inc. lifted its position in shares of Bath & Body Works by 7.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after buying an additional 781,681 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares during the period. Alliancebernstein L.P. lifted its holdings in Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after purchasing an additional 315,738 shares during the last quarter. Cooper Creek Partners Management LLC boosted its position in Bath & Body Works by 42.7% during the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock worth $162,081,000 after purchasing an additional 1,619,276 shares during the period. Finally, AQR Capital Management LLC increased its holdings in shares of Bath & Body Works by 5.3% in the second quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company’s stock valued at $125,322,000 after purchasing an additional 210,153 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Trading Up 0.4%

Shares of BBWI opened at $20.02 on Friday. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $41.87. The firm’s 50 day moving average is $22.32 and its 200-day moving average is $26.72. The stock has a market capitalization of $4.10 billion, a PE ratio of 6.16, a P/E/G ratio of 0.74 and a beta of 1.51.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm posted $0.49 earnings per share. The company’s quarterly revenue was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Friday, November 21st were given a $0.20 dividend. The ex-dividend date was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. The Goldman Sachs Group cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and cut their target price for the stock from $39.00 to $17.00 in a research note on Thursday, November 20th. JPMorgan Chase & Co. lowered their price target on shares of Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating on the stock in a report on Thursday, November 20th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $38.00 to $17.00 in a report on Friday, November 21st. Finally, Guggenheim initiated coverage on Bath & Body Works in a research note on Tuesday. They set a “neutral” rating on the stock. Five investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $23.54.

Insider Buying and Selling

In related news, Director Lucy Brady purchased 3,470 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average price of $14.40 per share, with a total value of $49,968.00. Following the completion of the purchase, the director directly owned 17,482 shares in the company, valued at $251,740.80. This trade represents a 24.76% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Francis Hondal acquired 3,343 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average cost of $14.99 per share, with a total value of $50,111.57. Following the transaction, the director directly owned 21,554 shares of the company’s stock, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 33,513 shares of company stock worth $500,442 in the last ninety days. 0.26% of the stock is owned by company insiders.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.